Single-Dose HPV Vaccination Among Young Adult Women in Costa Rica: the PRISMA-ESCUDDO Trial (PRevencIón Del Cáncer Cervical Con Una Sola Dosis de Vacuna Contra VPH en Mujeres Adultas Jóvenes)
Latest Information Update: 09 May 2025
At a glance
- Drugs Human papillomavirus vaccine recombinant bivalent Japan Vaccine/MedImmune (Primary) ; V 503 (Primary) ; DTaP vaccine
- Indications Human papillomavirus infections
- Focus Therapeutic Use
- Acronyms PRISMA; PRISMA-ESCUDDO
Most Recent Events
- 01 Sep 2023 Status changed from recruiting to active, no longer recruiting.
- 02 Mar 2022 Status changed from not yet recruiting to recruiting.
- 08 Feb 2022 Status changed to not yet recruiting.